Astrazeneca's Immuno-oncology Candidate Shows Promise
Add bookmark
What is Immuno-oncology: Immuno-oncology is a therapeutic approach that stimulates the body’s immune system to attack tumours. Oncology is undoubtedly one of the most active R&D areas in pharma. The immunotherapeutic field is in its infancy and contains a variety of areas including immune checkpoint inhibitors, cancer vaccines and monoclonal and conjugated antibodies.AstraZeneca and its global biologics research and development arm, MedImmune recently announced updated efficacy and saf...
